Strategic Partner I  Partner with us I  Careers I Announcement  I Contact Us  I Search 
Login
MangalKeshav Toolbar I  Ticker I   Important Documents
Market Overview Equity Corporate Announcements  Board Meetings
28 Jan,15 09:19:47
BSE
NSE
 «« +1 ««-1
BOARD MEETINGS
Board of director’s meeting held in the company for the purpose of Results, AGM etc. By default shows Today’s board meetings with purpose.
Click on any of the company name to go the company’s profile page.
 
Company BSE Code Date Purpose
   Foseco India 500150 28-Jan-15 Foseco India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 28, 2015, inter alia, to consider, approve and take on record the Audited Financial Results of the Company for the quarter and year ended December 31, 2014 and also to consider, if thought fit, to recommend the final dividend for the financial year ended December 31, 2014. 
   Envair Electrody 500246 28-Jan-15 Quarterly Results 
   Pidilite Inds. 500331 28-Jan-15 Pidilite Industries Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 28, 2015, inter alia, to consider and take on record the unaudited financial results (provisional) for the third quarter and 9 months ended on December 31, 2014 (Q3). 
   Ranbaxy Labs. 500359 28-Jan-15 Ranbaxy Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 28, 2015, inter alia, to consider and approve Standalone and Consolidated Unaudited Financial Results for the third quarter and nine months ending December 31, 2014 (Q3) as reviewed by the Statutory Auditors of the Company. Further, Trading window will remain closed from January 15, 2015 to January 29, 2015 (both days inclusive) in terms of the provisions of the Company's Code for Prevention for Insider Trading. 
   Torrent Pharma. 500420 28-Jan-15 Quarterly Results Torrent Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 28, 2015, inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company tor the quarter and nine months ended on December 31, 2014 (Q3). Further, as per the provisions of the Insider Trading Code of the Company, the trading window will remain closed between January 01, 2015 to January 29, 2015 (Board meeting for, inter alia, considering above results being held on January 28, 2015). (As Per BSE Announcement dated on 30/12/2014) With reference to the earlier letter dated December 30, 2014 intimating about the date of the meeting of the Board of Directors of the Company to be held on January 28, 2015 for, inter alia, considering and approving the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on December 31, 2014, Torrent Pharmaceuticals Ltd has now informed BSE that in the above meeting the Board would also consider payment of Interim Dividend for the year 2014-15. (As Per BSE Announcement dated on 15/01/2015) 
   NOCIL 500730 28-Jan-15 Quarterly Results 
   EIH 500840 28-Jan-15 EIH Ltd has informed BSE that the Trading Window for purchase / sale of Company's shares shall remain closed from January 21, 2015 till January 29, 2015 (both days inclusive) in terms of Company's Code of Conduct for Insider Trading in view of the Board Meeting scheduled to be held on January 28, 2015 for approval of Unaudited Financial Results for quarter ended on December 31, 2014. 
   St Bk of Bikaner 501061 28-Jan-15 Quarterly Results 
   Rose Invest. 501154 28-Jan-15 Quarterly Results 
   Sintex Inds. 502742 28-Jan-15 Sintex Industries Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 28, 2015, for considering the Unaudited Financial Results for the Quarter ended on December 31, 2014 (Q3). 
[Back] [Top]
  Broker Norms I SSL Certificate I  Disclaimer  I  Privacy Policy I  Fraud Prevention  I  Investor Complaint Cell I Investor Protection I Sitemap
© 2008 Mangal Keshav Securities Ltd. All rights reserved
Designed, developed & maintained by C-MOTS Infotech(ISO 9001:2008 certified) Content powered by Capital Market

  • INVESTOR GRIEVANCES : investorgrievances@mangalkeshav.com 
  • EQUITY AND DERIVATIVE TRADING, DEPOSITORY, INTERNET TRADING THROUGH MANGAL KESHAV SECURITIES LTD. : Member BSE (Cash & Derivatives): SEBI Regn. No. INB 010977431 & INF 010977431 ; Member NSE (Cash & Derivatives): SEBI Regn. No. INB 230977432 & INF230977432 ; Member MCX-SX (Cash, Derivatives & Currency Derivatives): SEBI Regn. No. INB260977435, INF260977435 & INE260977435 ; NSDL: SEBI Regn. No. IN – DP – NSDL – 229 – 2002 ; CDSL: SEBI Regn. No. IN – DP – CDSL – 153 – 2001 ; AMFI Regn. No. ARN 2397 
  • COMMODITY BROKING THROUGH MK COMMODITY BROKERS LTD. : Member MCX (Regn No. 12620, FMC Code: MCX/TCM/CORP/0700) ; Member NCDEX (Regn. No. 00042, FMC Code: NCDEX/TCM/CORP/0134);Member NSEL (Mebership Code 14520)
  • INSURANCE THROUGH MANGAL KESHAV INSURANCE BROKERS LTD. : IRDA License No. 202
  • IPO AND MUTUAL FUNDS THROUGH MANGAL KESHAV FINANCIAL SERVICES LTD. : AMFI Regn. No. ARN 22771
  • MANGAL KESHAV CAPITAL LTD. : N – 13.01824
OFFICE ADDRESS : 501, 5th floor, Heritage Plaza, Opp. Indian Oil Nagar, J P Road, Andheri (w) – 400053 I Tel.:- 022-3386 8000